Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The price of Dyne Therapeutics Inc (NASDAQ: DYN) closed at $42.86 in the last session, up 0.07% from day before closing price of $42.83. In other words, the price has increased by $0.07 from its previous closing price. On the day, 0.55 million shares were traded. DYN stock price reached its highest trading level at $44.14 during the session, while it also had its lowest trading level at $42.0501.
Ratios:
We take a closer look at DYN’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 21.83 and its Current Ratio is at 21.83. In the meantime, Its Debt-to-Equity ratio is 0.06 whereas as Long-Term Debt/Eq ratio is at 0.05.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Chardan Capital Markets on May 21, 2024, Reiterated its Buy rating but revised its target price to $42 from $31 previously.
On April 30, 2024, Morgan Stanley started tracking the stock assigning a Overweight rating and target price of $40.
On February 20, 2024, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $36.H.C. Wainwright initiated its Buy rating on February 20, 2024, with a $36 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jun 24 ’24 when HIGH SUSANNA GATTI sold 10,163 shares for $35.33 per share. The transaction valued at 359,059 led to the insider holds 148,792 shares of the business.
HIGH SUSANNA GATTI sold 29,787 shares of DYN for $1,042,843 on Jun 21 ’24. The Chief Operating Officer now owns 148,792 shares after completing the transaction at $35.01 per share. On Jun 12 ’24, another insider, HIGH SUSANNA GATTI, who serves as the Chief Operating Officer of the company, sold 40,000 shares for $33.36 each. As a result, the insider received 1,334,201 and left with 148,792 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, DYN now has a Market Capitalization of 4262752768 and an Enterprise Value of 3318289920.
Stock Price History:
Over the past 52 weeks, DYN has reached a high of $45.46, while it has fallen to a 52-week low of $6.40. The 50-Day Moving Average of the stock is 20.67%, while the 200-Day Moving Average is calculated to be 87.60%.
Shares Statistics:
According to the various share statistics, DYN traded on average about 1.25M shares per day over the past 3-months and 865070 shares per day over the past 10 days. A total of 97.88M shares are outstanding, with a floating share count of 68.32M. Insiders hold about 30.20% of the company’s shares, while institutions hold 68.23% stake in the company. Shares short for DYN as of 1721001600 were 9242110 with a Short Ratio of 7.38, compared to 1718323200 on 10032260. Therefore, it implies a Short% of Shares Outstanding of 9242110 and a Short% of Float of 11.08.
